SCHEMBL7071470

SCHEMBL7071470

Cc1cnc(NCc2cccs2)nc1NCc1ccc(C(=O)O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP1 O94782 2/20 0.51
WDR48 Q8TAF3 2/20 0.51
HDAC6 Q9UBN7 2/20 0.49
HDAC3 O15379 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC2 Q92769 1/20 0.49
SIRT5 Q9NXA8 1/20 0.46
POLB P06746 1/20 0.45
CYP1A2 P05177 4/20 0.44
CYP3A4 P08684 4/20 0.44
CYP2D6 P10635 4/20 0.44
CYP2C19 P33261 4/20 0.44
ALOX15 P16050 2/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
TSHR P16473 3/20 0.43
MEN1 O00255 2/20 0.43
USP2 O75604 2/20 0.43
KMT2A Q03164 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7071479 0.90 USP1 (0.49) USP1WDR48HDAC6HDAC3HDAC1
SCHEMBL7071101 0.79 ADORA2A (0.53)
SCHEMBL7258507 0.76 HRH4 (0.55) POLBCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL7254511 0.75 LMNA (0.56) CYP1A2CYP3A4CYP2D6CYP2C19ALOX15
SCHEMBL7257480 0.73 USP1 (0.59) USP1WDR48CYP1A2CYP3A4CYP2D6
SCHEMBL11413736 0.71 L3MBTL1 (0.66) HDAC6HDAC3HDAC1HDAC2POLB
SCHEMBL7066909 0.70 ADORA2A (0.48) HPGD
SCHEMBL2899932 0.69 KDM4C (0.53) HDAC6HDAC3HDAC1HDAC2POLB
SCHEMBL3442903 0.68 KDM4C (0.53) HDAC6HDAC3HDAC1HDAC2POLB
SCHEMBL11185388 0.68 HDAC1 (0.58) HDAC6HDAC3HDAC1HDAC2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003055489-A1 2,4-DIAMINO-PYRIMIDINE DERIVATIVE COMPOUNDS AS INHIBITORS OF PROLYLPEPTIDASE, INDUCERS OF APOPTOSIS AND CANCER TREATMENT AGENTS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-10 WO disclosed